- Home
- WINA vs IMCR Comparison
WINA vs IMCR Comparison
Compare WINA & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WINA
- IMCR
- Stock Information
- Founded
- WINA 1988
- IMCR 2008
- Country
- WINA United States
- IMCR United Kingdom
- Employees
- WINA N/A
- IMCR N/A
- Industry
- WINA Other Specialty Stores
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WINA Consumer Discretionary
- IMCR Health Care
- Exchange
- WINA Nasdaq
- IMCR Nasdaq
- Market Cap
- WINA 1.4B
- IMCR 1.5B
- IPO Year
- WINA 1993
- IMCR 2021
- Fundamental
- Price
- WINA $396.66
- IMCR $30.00
- Analyst Decision
- WINA Strong Buy
- IMCR Buy
- Analyst Count
- WINA 1
- IMCR 13
- Target Price
- WINA $445.00
- IMCR $65.18
- AVG Volume (30 Days)
- WINA 18.7K
- IMCR 298.2K
- Earning Date
- WINA 02-19-2025
- IMCR 02-26-2025
- Dividend Yield
- WINA 0.66%
- IMCR N/A
- EPS Growth
- WINA N/A
- IMCR N/A
- EPS
- WINA 10.93
- IMCR N/A
- Revenue
- WINA $81,781,000.00
- IMCR $296,312,000.00
- Revenue This Year
- WINA $0.47
- IMCR $28.91
- Revenue Next Year
- WINA $4.86
- IMCR $12.65
- P/E Ratio
- WINA $35.90
- IMCR N/A
- Revenue Growth
- WINA N/A
- IMCR 25.09
- 52 Week Low
- WINA $330.25
- IMCR $27.69
- 52 Week High
- WINA $431.67
- IMCR $76.98
- Technical
- Relative Strength Index (RSI)
- WINA 53.05
- IMCR 50.53
- Support Level
- WINA $365.83
- IMCR $28.22
- Resistance Level
- WINA $391.04
- IMCR $30.77
- Average True Range (ATR)
- WINA 7.08
- IMCR 1.35
- MACD
- WINA 0.85
- IMCR 0.08
- Stochastic Oscillator
- WINA 95.10
- IMCR 51.90
About WINA Winmark Corporation
Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment including Franchising and one non-reportable segment Leasing. The franchising segment franchises value-oriented retail store that buys, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.